Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 157Carcinoma, Intraductal, Noninfiltrating 16Breast Carcinoma In Situ 12Neoplasm Metastasis 9Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasms 4Prostatic Neoplasms 3Inflammatory Breast Neoplasms 3Glioblastoma 3Breast Cancer Female 3Urinary Bladder Neoplasms 2Recurrence 2Pancreatic Neoplasms 2Obesity 2Infertility 2Hot Flashes 2Fibroadenoma 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2ER+ Breast Cancer 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sleep Wake Disorders 1Sexuality 1Risk Reduction Behavior 1Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Primary Breast Cancer 1

Interventions

Surveys and Questionnaires 3Blood Specimen Collection 3Salpingo-oophorectomy 2Genetic Testing 2Genetic Counseling 2Diet, Mediterranean 2Counseling 2Videotape Recording 1Telemedicine 1Tamoxifen 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Salpingectomy 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Palliative Care 1Ovariectomy 1Methods 1Letrozole 1Hysterectomy 1High-Throughput Nucleotide Sequencing 1Genotype 1Exercise Test 1Echocardiography 1Early Intervention, Educational 1CA-125 Antigen 1Buthionine Sulfoximine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hereditary Breast and Ovarian Cancer Syndrome × Tamoxifen × Clear all
NCT00253539 2011-04-13

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

The Cleveland Clinic

Phase 2 Completed
3 enrolled
BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡